--- title: "NanoViricides (NNVC) news: offering" url: "https://aibio.space/companies/nanoviricides/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "NNVC offering news: NanoViricides closes registered direct offering with gross proceeds of about $6.0 million. NanoViricides, Inc." --- NNVC NanoViricides, Inc. AMEX · United States # NanoViricides (NNVC) news NNVC offering news Financings · 2025-11-14 ## [NanoViricides closes registered direct offering with gross proceeds of about $6.0 million](https://aibio.space/news/nanoviricides-closes-registered-direct-offering-gross-proceeds-about-6/) The company sold 1,970,000 shares at $1.68 per share and pre-funded warrants for up to 1,601,429 shares to one investor, and issued Series A and Series B warrants in a concurrent private placement. ## Latest NanoViricides news We have not published a story on NanoViricides yet. When there is news, it will appear here. ## NanoViricides at a glance - **Ticker**: NNVC - **Listing**: AMEX - **Country**: United States - **Cash, Jun 30, 2026**: $2.8 million ### Related companies - [Eledon Pharmaceuticals](https://aibio.space/companies/eledon-pharmaceuticals/) NASDAQ: ELDN - [Zeo ScientifiX](https://aibio.space/companies/zeo-scientifix/) OTC: ZEOX - [Travere Therapeutics](https://aibio.space/companies/travere-therapeutics/) NASDAQ: TVTX - [Acrivon Therapeutics](https://aibio.space/companies/acrivon-therapeutics/) NASDAQ: ACRV - [Genelux](https://aibio.space/companies/genelux/) NASDAQ: GNLX - [Aquestive Therapeutics](https://aibio.space/companies/aquestive-therapeutics/) NASDAQ: AQST - [Cytokinetics](https://aibio.space/companies/cytokinetics/) NASDAQ: CYTK - [Acura Pharmaceuticals](https://aibio.space/companies/acura-pharmaceuticals/) OTC: ACUR ### Also on AMEX - [Matinas Biopharma Holdings](https://aibio.space/companies/matinas-biopharma/) MTNB - [AIM ImmunoTech](https://aibio.space/companies/aim-immunotech/) AIM - [Armata Pharmaceuticals](https://aibio.space/companies/armata-pharmaceuticals/) ARMP - [IGC Pharma](https://aibio.space/companies/igc-pharma/) IGC - [Impact BioMedical](https://aibio.space/companies/impact-biomedical/) IBO - [Cel-Sci](https://aibio.space/companies/cel-sci/) CVM ## NanoViricides annual financials | Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 | |---|---|---| | Research and development | [$4.7 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | [$5.5 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | | Net income (loss) | [-$8.2 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | [-$9.5 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | | Cash from operations | [-$7.7 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | [-$8.5 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | | Cash and equivalents | [$2.8 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | [$1.6 million](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/) | Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $2.8 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about NanoViricides Has NanoViricides raised money recently? Our latest story on this, dated Nov 14, 2025: "NanoViricides closes registered direct offering with gross proceeds of about $6.0 million". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/nanoviricides-closes-registered-direct-offering-gross-proceeds-about-6/). What is the ticker symbol of NanoViricides? NanoViricides, Inc. trades under the ticker NNVC on AMEX. Where is NanoViricides listed? NanoViricides, Inc. is listed on AMEX. Our directory also records these other listings: GETTEX:NV3P. What is the SEC CIK of NanoViricides? The SEC Central Index Key (CIK) for NanoViricides, Inc. is 1379006. Its filings are on SEC EDGAR. How many shares does NanoViricides have outstanding? 25,525,000 shares as of 2026-09-28, per the cover page of its 10-K filed 2026-09-28. Which country or territory is NanoViricides listed under? Our directory records NanoViricides, Inc. under United States. What does NanoViricides do? Our directory classifies NanoViricides, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of NanoViricides? The ISIN recorded for NanoViricides, Inc. is US6300873022. Does aibio.space cover NanoViricides? aibio.space lists NanoViricides, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is NanoViricides incorporated? SEC records list its state or country of incorporation as DE. Is NanoViricides profitable? NanoViricides, Inc. reported a net loss of $8.2 million for the fiscal year ended Jun 30, 2026, and used $7.7 million of cash in operations, per its annual report to the SEC. How much does NanoViricides spend on research and development? $4.7 million in the fiscal year ended Jun 30, 2026, per its annual report. How much cash does NanoViricides have? $2.8 million in cash at Jun 30, 2026, per its 10-K. What is the latest NanoViricides (NNVC) stock news? Our latest story on NanoViricides, dated Nov 14, 2025: "NanoViricides closes registered direct offering with gross proceeds of about $6.0 million". The company sold 1,970,000 shares at $1.68 per share and pre-funded warrants for up to 1,601,429 shares to one investor, and issued Series A and Series B warrants in a concurrent private placement. [Source](https://aibio.space/news/nanoviricides-closes-registered-direct-offering-gross-proceeds-about-6/). What is NanoViricides's market cap? We do not publish live share prices. In its annual report, NanoViricides, Inc. put the market value of shares held by non-affiliates (public float) at $23.7 million as of Dec 31, 2025. ## Investor discussion: NanoViricides Members talk about NanoViricides (NNVC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at NanoViricides, newest first. Each line links the filing it comes from. 1. 2026-09-28 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/nnvc-20260630x10k.htm) 2. 2026-05-18 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1379006/000110465926063050/tm2614900d1_424b5.htm) 3. 2025-09-29 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1379006/000110465925094527/nnvc-20250630x10k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open AMEX:NNVC on TradingView](https://www.tradingview.com/symbols/AMEX-NNVC/). ## SEC filings and registration - **SEC name**: Nanoviricides, Inc. - **CIK**: 1379006 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: NNVC (NYSE) - **State or country of incorporation**: DE - **Fiscal year ends**: June 30 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 1 CONTROLS DRIVE, SHELTON, CT, 06484 - **Phone**: (203) 668-5580 - **Shares outstanding**: 25,525,000 as of 2026-09-28 (10-K filed 2026-09-28) ### Recent filings (8-K and 6-K are the company's own announcements) - [424B5](https://www.sec.gov/Archives/edgar/data/1379006/000110465926117595/tm2627711d1_424b5.htm) filed 2026-10-21 - [DEF 14A](https://www.sec.gov/Archives/edgar/data/1379006/000110465926114606/tm2626953d1_def14a.htm) filed 2026-10-08 - [8-K](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111952/tm2626486d1_8k.htm) filed 2026-09-29 - [10-K](https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/nnvc-20260630x10k.htm) filed 2026-09-28 - [S-3](https://www.sec.gov/Archives/edgar/data/1379006/000110465926099705/tm2623571d1_s3.htm) filed 2026-08-21 - [8-K](https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/tm2621493d1_8k.htm) filed 2026-07-30 - [424B5](https://www.sec.gov/Archives/edgar/data/1379006/000110465926086797/tm2621359d1_424b5.htm) filed 2026-07-27 - [424B5](https://www.sec.gov/Archives/edgar/data/1379006/000110465926086767/tm2621359d2_424b5.htm) filed 2026-07-27 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001379006), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details NanoViricides, Inc. is a public biotech or pharmaceutical company listed on AMEX under the ticker NNVC, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: NanoViricides, Inc. - **Ticker**: NNVC - **Listing**: AMEX - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US6300873022 - **Other listed symbols**: GETTEX:NV3P - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/AMEX-NNVC/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/nanoviricides/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "NanoViricides (NNVC) news: offering", 2026-10-31, https://aibio.space/companies/nanoviricides/